Literature DB >> 29465270

Hypomethylating agents (HMAs) effect on myelodysplastic/myeloproliferative neoplasm unclassifiable (MDS/MPN-U): single institution experience.

Aref Al-Kali1, Ahmed Kamel Abou Hussein1, Mrinal Patnaik1, Darci Zblewski1, Naseema Gangat1, Shahrukh Hashmi1, Michelle Elliott1, William Hogan1, Mark Litzow1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29465270     DOI： 10.1080/10428194.2018.1436705

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  3 in total

Review 1.  Treatment of MDS/MPN and the MDS/MPN IWG International Trial: ABNL MARRO.

Authors:  Andrew T Kuykendall; Eric Padron
Journal:  Curr Hematol Malig Rep       Date:  2019-12       Impact factor: 3.952

2.  Mutational landscape of myelodysplastic/myeloproliferative neoplasm-unclassifiable.

Authors:  Prithviraj Bose; Aziz Nazha; Rami S Komrokji; Keyur P Patel; Sherry A Pierce; Najla Al-Ali; Andrew Sochacki; Aaron Shaver; Wencai Ma; Xiaoping Su; Naval G Daver; Courtney D DiNardo; Guillermo Garcia-Manero; Sanam Loghavi; Carlos Bueso-Ramos; Hagop M Kantarjian; Mikkael A Sekeres; Michael R Savona; Jaroslaw P Maciejewski; Srdan Verstovsek
Journal:  Blood       Date:  2018-09-21       Impact factor: 25.476

3.  Myelodysplastic/myeloproliferative neoplasms-unclassifiable with isolated isochromosome 17q represents a distinct clinico-biologic subset: a multi-institutional collaborative study from the Bone Marrow Pathology Group.

Authors:  Rashmi Kanagal-Shamanna; Attilio Orazi; Robert P Hasserjian; Daniel A Arber; Kaaren Reichard; Eric D Hsi; Adam Bagg; Heesun Joyce Rogers; Julia Geyer; Faezeh Darbaniyan; Kim-Anh Do; Kyle M Devins; Olga Pozdnyakova; Tracy I George; Paola Dal Cin; Patricia T Greipp; Mark J Routbort; Keyur Patel; Guillermo Garcia-Manero; Srdan Verstovsek; L Jeffrey Medeiros; Sa A Wang; Carlos Bueso-Ramos
Journal:  Mod Pathol       Date:  2021-11-13       Impact factor: 7.842
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.